Global General Anesthesia Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type, By Route of Administration, By Application, By End-User, By Form, By Region, Segment Forecast, 2024-2031
- Published Date : 2024-10-01
- Pages : 100
- Report Id : 40479
- Categories : Healthcare
This report describes the global market size of the General Anesthesia Drugs Market from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and is expected to grow with a CAGR of 3.8% from 2024 to 2031.
Due to the COVID-19 pandemic and the Russia-Ukraine War Influence, the global market for General Anesthesia Drugs Market estimated at US $15.25 Billion in the year 2022, is projected to reach a revised size of US $ 29.41 Billion by 2031, growing at a CAGR of 3.8% during the forecast period 2024-2031.
General anesthesia drugs are medications used to induce a reversible state of unconsciousness, muscle relaxation, and loss of sensation in patients undergoing surgery or other medical procedures. These drugs are typically administered through inhalation (gases or vapors) or intravenous (IV) injections, ensuring that the patient remains unaware and pain-free during the operation. Common agents include propofol, sevoflurane, isoflurane, and barbiturates. The drugs work by affecting the central nervous system, inhibiting nerve signal transmission, and depressing brain activity. General anesthesia typically involves three phases: induction (putting the patient to sleep), maintenance (keeping them unconscious), and emergence (waking the patient). The administration is carefully monitored by an anesthesiologist to ensure the patient s vital signs remain stable. The dosage and combination of drugs used depend on factors like the type of surgery, patient s age, health condition, and medical history.
For the geography segment, regional supply, demand, major players, and price is presented from 2019 to 2031. This report covers the following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report include global key players of General Anesthesia Drugs Market as well as some small players. The information for each competitor includes:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Drug Type
Propofol
Sevoflurane
Desflurane
Isoflurane
Ketamine
Midazolam
Fentanyl
Others
General anesthesia drugs can be categorized into various types based on their specific actions and uses during surgery. Propofol is a widely used intravenous agent that induces quick and smooth unconsciousness, often preferred for short procedures. Sevoflurane and Desflurane are inhalation agents, known for their rapid onset and quick recovery, making them useful in maintaining anesthesia during longer surgeries. Isoflurane, another inhaled anesthetic, is effective for maintaining anesthesia in a stable, controlled manner, although it may have a slower onset compared to others.
Ketamine is unique in that it provides both anesthesia and pain relief while preserving some protective airway reflexes, making it valuable in trauma cases. Midazolam is a benzodiazepine used for preoperative sedation and amnesia, reducing anxiety and providing muscle relaxation. Fentanyl, a potent opioid, is used for pain relief during surgery, often in combination with other anesthetic agents to minimize the need for higher doses of anesthesia. Other drugs, such as etomidate and thiopental, may also be used depending on specific patient needs and the nature of the procedure. Each drug is chosen based on factors like speed of action, duration of surgery, and patient-specific considerations like age, health, and medical history.
By Route of Administration
Intravenous
Inhalational
General anesthesia drugs are primarily administered through two main routes: intravenous (IV) and inhalational. Intravenous anesthesia involves delivering drugs directly into the bloodstream through a vein, leading to a rapid onset of unconsciousness. Common IV agents include propofol, ketamine, and midazolam. These drugs act quickly and are often used for the induction phase, where the patient is initially put to sleep. Inhalational anesthesia, on the other hand, involves administering anesthetic gases or vapors like sevoflurane, desflurane, or isoflurane through a mask or breathing tube. This route is often used for maintaining anesthesia during longer procedures, as it allows for easy adjustments in the depth of anesthesia by varying the concentration of gases. The choice of route depends on the patient's condition, the type of procedure, and the desired speed of action and recovery.
By Application
Surgical Procedures
General Surgery
Cardiac Surgery
Neurological Surgery
Orthopedic Surgery
Others
Non-Surgical Procedures
Diagnostic Procedures
Pain Management
General anesthesia drugs are widely used in both surgical and non-surgical procedures to ensure patient comfort and safety. In surgical procedures, anesthesia is essential for a range of operations. General surgery involves procedures like appendectomies or hernia repairs, where anesthesia allows the patient to remain unconscious and pain-free. Cardiac surgery, such as open-heart surgery, requires deep and controlled anesthesia to manage the patient s vitals while the heart is operated on. Neurological surgery, including brain or spinal procedures, demands precise anesthesia to protect the brain and central nervous system while allowing the surgeon to work on delicate areas. Orthopedic surgery, involving bones and joints, also requires anesthesia to ensure muscle relaxation and prevent pain during procedures like joint replacements or fracture repairs. Other types of surgeries, from gastrointestinal to urological, also rely on anesthesia for effective patient management. In non-surgical procedures, general anesthesia may be used during diagnostic procedures like endoscopies or imaging tests that require the patient to remain still and comfortable. It can also be applied in pain management scenarios, such as for chronic pain treatments or during certain nerve block procedures. In both surgical and non-surgical contexts, anesthesia ensures that the patient remains unaware of the procedure, minimizing discomfort and facilitating smoother interventions.
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
Clinics
Others
General anesthesia drugs are used across various healthcare settings depending on the type and complexity of the procedure. Hospitals are the primary end-users, especially for major surgeries like cardiac, neurological, and orthopedic procedures, where comprehensive facilities and critical care are needed. Ambulatory Surgery Centers (ASCs), which handle outpatient surgeries, also frequently use anesthesia for procedures that require shorter recovery times, such as minor orthopedic or cosmetic surgeries. Clinics often administer general anesthesia for smaller-scale procedures, including dental surgeries or certain diagnostic tests that may still require sedation. Other settings include specialized care facilities or pain management centers, where anesthesia may be used for non-surgical interventions. The end-user environment determines the anesthesia protocol, with hospitals typically having more extensive monitoring and emergency capabilities than ASCs or clinics.
Key Players
Baxter International Inc.
AstraZeneca
AbbVie Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KgaA
Pfizer
Hospira Inc.
Aspen Pharmacare Holdings Limited
Hikama Pharmaceuticals plc
Abbott Laboratories
Please ask for sample pages for the full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
TABLE OF CONTENTS
Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.General Anesthesia Drugs Market Outlook
3.1.2.General Anesthesia Drugs Market Overview
3.2. Effect of Covid-19 Impact
3.3. Macro-Economic Overview
3.3.1. GDP Growth
3.3.2. Retail Industry Growth
3.4. Pricing Analysis
3.5. Challenges related to adoption of General Anesthesia Drugs Market
3.6. Regulations of General Anesthesia Drugs Market
3.7. Forecast Factors: Relevance and Impact
3.8. Market Dynamics
3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunity
3.8.4. Trends
3.8.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global General Anesthesia Drugs Market Value Chain Analysis
5.1.General Anesthesia Drugs Market Value Chain
5.1.1. List of Raw Route of Administration Suppliers
5.1.2. List of General Anesthesia Drugs Market Manufacturer
5.1.3. List of Segment
6. Global General Anesthesia Drugs Market Analysis by Drug Type
6.1. Introduction
6.1.1. Market Value Share Analysis By Drug Type
6.1.2. Y-o-Y Growth Analysis By Drug Type
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Drug Type
6.3. Market Attractiveness Analysis by Drug Type
7. GlobalGeneral Anesthesia Drugs Market Analysis By Route of Administration
7.1. Introduction
7.1.1. Market Value Share Analysis By Route of Administration
7.1.2. Y-o-Y Growth Analysis By Route of Administration
7.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Route of Administration
7.3. Market Attractiveness Analysis By Route of Administration
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Drug Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Drug Type Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1.Baxter International Inc.
9.2.1.1. Overview
9.2.1.2. Drug Type Portfolio
9.2.1.3. Financial Overview
9.2.2. AstraZeneca
9.2.2.1. Overview
9.2.2.2. Drug Type Portfolio
9.2.2.3. Financial Overview
9.2.3. AbbVie Inc.
9.2.3.1. Overview
9.2.3.2. Drug Type Portfolio
9.2.3.3. Financial Overview
9.2.4. B. Braun Melsungen AG
9.2.4.1. Overview
9.2.4.2. Drug Type Portfolio
9.2.4.3. Financial Overview
9.2.5. Fresenius SE & Co. KgaA
9.2.5.1. Overview
9.2.5.2. Drug Type Portfolio
9.2.5.3. Financial Overview
9.2.6.Pfizer
9.2.6.1. Overview
9.2.6.2. Drug Type Portfolio
9.2.6.3. Financial Overview
9.2.7.Hospira Inc.
9.2.7.1. Overview
9.2.7.2. Drug Type Portfolio
9.2.7.3. Financial Overview
9.2.8.Aspen Pharmacare Holdings Limited
9.2.8.1. Overview
9.2.8.2. Drug Type Portfolio
9.2.8.3. Financial Overview
9.2.9. Hikama Pharmaceuticals plc
9.2.9.1. Overview
9.2.9.2. Drug Type Portfolio
9.2.9.3. Financial Overview
9.2.10.Abbott Laboratories
9.2.10.1. Overview
9.2.10.2. Drug Type Portfolio
9.2.10.3. Financial Overview
9.2.11.COMPANY 11
9.2.11.1. Overview
9.2.11.2. Drug Type Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY 12
9.2.12.1. Overview
9.2.12.2. Drug Type Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY 13
9.2.13.1. Overview
9.2.13.2. Drug Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY 14
9.2.14.1. Overview
9.2.14.2. Drug Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY 15
9.2.15.1. Overview
9.2.15.2. Drug Type Portfolio
9.2.15.3. Financial Overview
10. Global General Anesthesia Drugs Market Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y-o-Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia-Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia-Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America General Anesthesia Drugs Market Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Drug Type
11.5. Current Market Size (USD Mn) Forecast 2023-2030 By Drug Type
11.6. Historical Market Size (USD Mn) Analysis 2018-2022 By Route of Administration
11.7. Current Market Size (USD Mn) Forecast 2023-2030 By Route of Administration
12. South America General Anesthesia Drugs Market Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Drug Type
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Drug Type
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Route of Administration
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By Route of Administration
13. Europe General Anesthesia Drugs Market Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Drug Type
13.6. Current Market Size (USD Mn) Forecast 2023-2030 By Drug Type
13.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Route of Administration
13.8. Current Market Size (USD Mn) Forecast 2023-2030 By Route of Administration
14. Middle East and Africa General Anesthesia Drugs Market Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia-Pacific General Anesthesia Drugs Market Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia-Pacific
15.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms
LIST OF FIGURES
Figure 01: Global General Anesthesia Drugs Market, BPS Analysis,By Drug Type, 2018(H), 2023(E) & 2030(F)
Figure 02: Global General Anesthesia Drugs Market, Y-O-Y Growth,By Drug Type, 2020(A) - 2030(F)
Figure 03: Global General Anesthesia Drugs Market Attractiveness Analysis,By Drug Type (2020)
Figure 04: Global General Anesthesia Drugs Market, BPS Analysis, By Route of Administration, 2018(H), 2023(E) & 2030(F)
Figure 05: Global General Anesthesia Drugs Market, Y-O-Y Growth, By Route of Administration, 2018(H) - 2030(F)
Figure 06: Global General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
Figure 07: Global General Anesthesia Drugs Market, Value Analysis,By Drug Type, 2018(H)-2030(F)
Figure 08: Global General Anesthesia Drugs Market, Value Analysis, by Route of Administration , 2018(H)-2030(F)
Figure 09: Global General Anesthesia Drugs Market, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global General Anesthesia Drugs Market, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global General Anesthesia Drugs Market Attractiveness Analysis, by Region
Figure 12: North America General Anesthesia Drugs Market Value (USD Mn Forecast, 2018 – 2022
Figure 13: North America General Anesthesia Drugs Market Value (USD Mn Forecast, 2023 – 2030
Figure 14: South America General Anesthesia Drugs Market Value (USD Mn) Forecast, 2018 – 2022
Figure 15: South America General Anesthesia Drugs Market Value (USD Mn) Forecast, 2023 – 2030
Figure 16: Europe General Anesthesia Drugs Market Value (USD Mn) Forecast, 2018 – 2022
Figure 17: Europe General Anesthesia Drugs Market Value (USD Mn) Forecast, 2023 – 2030
Figure 18: Middle East and Africa General Anesthesia Drugs Market Value (USD Mn) Forecast, 2018 – 2022
LIST OF TABLES
Table 01: Global General Anesthesia Drugs Market Value (USD Mn) Forecast, By Drug Type, 2018(H) – 2030(F)
Table 02: Global General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration, 2018(H) – 2030(F)
Table 03: Global General Anesthesia Drugs Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 04: North America General Anesthesia Drugs Market Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 05: North America General Anesthesia Drugs Market Value (USD Mn) Forecast,By Drug Type, 2018(H) – 2030(F)
Table 06: North America General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration, 2018(H) – 2030(F)
Table 07: South America General Anesthesia Drugs Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 08: South America General Anesthesia Drugs Market Value (USD Mn) Forecast,By Drug Type, 2018(H) – 2030(F)
Table 09: South America General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration, 2018(H) – 2030(F)
Table 10: Europe General Anesthesia Drugs Market Value (USD Mn) and Forecast, by Country, 2018(H) – 2030(F)
Table 11: Europe General Anesthesia Drugs Market Value (USD Mn) Forecast, By Drug Type, 2018(H) – 2030(F)
Table 12: Europe General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration EndUser, 2018(H) – 2030(F)
Table 13: Middle East and Africa General Anesthesia Drugs Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 14: Middle East and Africa General Anesthesia Drugs Market Value (USD Mn) Forecast, By Drug Type, 2018(H) – 2030(F)
Table 15: Middle East and Africa General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration, 2018(H) – 2030(F)
Table 16: Asia-Pacific General Anesthesia Drugs Market Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 17: Asia-Pacific General Anesthesia Drugs Market Value (USD Mn) Forecast, By Drug Type, 2018(H) – 2030(F)
Table 18: Asia-Pacific General Anesthesia Drugs Market Value (USD Mn) Forecast, By Route of Administration, 2018(H) – 2030(F)
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research ™ Copyright © 2024 .